Nan Yang, Su HongChan, Lian XiaoMei, Wu Juan, Liu SuJie, Chen PingPing, Liu ShuMin
Heilongjiang University of Chinese Medicine, College of Pharmacy, Heilongjiang, Haerbin 150040, China.
Heilongjiang University of Chinese Medicine, Chinese Medicine Research Institute, Heilongjiang, Haerbin 150040, China.
Evid Based Complement Alternat Med. 2022 Apr 28;2022:5325431. doi: 10.1155/2022/5325431. eCollection 2022.
Liver fibrosis is a pathological process of abnormal tissue proliferation in the liver caused by various pathogenic factors, which will further develop into cirrhosis or even hepatocellular carcinoma if liver injury is not intervened in time. As a diffuse progressive liver disease, its clinical manifestations are mostly excessive deposition of collagen-rich extracellular matrix resulting in scar formation due to liver injury. Hepatic fibrosis can be caused by hepatitis B and C, fatty liver, alcohol, and rare diseases such as hemochromatosis. As the metabolic center of the body, the liver regulates various vital activities. During the development of fibrosis, it is influenced by many other factors in addition to the central event of hepatic stellate cell activation. Currently, with the increasing understanding of TCM, the advantages of TCM with multiple components, pathways, and targets have been demonstrated. In this review, we will describe the factors influencing liver fibrosis, focusing on the effects of cells, intestinal flora, iron death, signaling pathways, autophagy and angiogenesis on liver fibrosis, and the therapeutic effects of herbal medicine on liver fibrosis.
Evid Based Complement Alternat Med. 2022-4-28
Front Cell Infect Microbiol. 2023
J Ethnopharmacol. 2020-4-6
Front Pharmacol. 2023-1-10
Front Pharmacol. 2022-2-11
Eur J Surg Suppl. 2002
Hepatol Res. 2014-10-14
Cell Mol Gastroenterol Hepatol. 2021